Tags

Type your tag names separated by a space and hit enter

Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nat Rev Drug Discov. 2020 03; 19(3):149-150.NR

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

News
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32127666

Citation

Li, Guangdi, and Erik De Clercq. "Therapeutic Options for the 2019 Novel Coronavirus (2019-nCoV)." Nature Reviews. Drug Discovery, vol. 19, no. 3, 2020, pp. 149-150.
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149-150.
Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews. Drug Discovery, 19(3), 149-150. https://doi.org/10.1038/d41573-020-00016-0
Li G, De Clercq E. Therapeutic Options for the 2019 Novel Coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149-150. PubMed PMID: 32127666.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Therapeutic options for the 2019 novel coronavirus (2019-nCoV). AU - Li,Guangdi, AU - De Clercq,Erik, PY - 2020/3/5/pubmed PY - 2020/3/24/medline PY - 2020/3/5/entrez SP - 149 EP - 150 JF - Nature reviews. Drug discovery JO - Nat Rev Drug Discov VL - 19 IS - 3 SN - 1474-1784 UR - https://www.unboundmedicine.com/medline/citation/32127666/Therapeutic_options_for_the_2019_novel_coronavirus__2019_nCoV__ DB - PRIME DP - Unbound Medicine ER -